Lois Katz

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

Faramarz Ismail‐Beigi, Timothy E. Craven, Mary Ann Banerji et al. · The Lancet · 2010 · 1.4K citations · Full text

Metabolic Syndrome, Diabetes Management, Health Policy +11

Cerebral organization of component processes in reading

K.R. Pugh, Bennett A. Shaywitz, Sally E. Shaywitz et al. · Brain · 1996 · 614 citations

Neuropsychology, Brain Function, Neurolinguistics +18

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Cognitive Profiles of Reading-Disabled Children: Comparison of Language Skills in Phonology, Morphology, and Syntax

Donald Shankweiler, Stephen Crain, Lois Katz et al. · Psychological Science · 1995 · 387 citations · Full text

Language Development, Education, Psycholinguistics +22